Sarah Doughan
About Sarah Doughan
Sarah Doughan is an experienced pharmaceutical production operator at Corealis Pharma Inc., where she has worked since 2014. She holds a DEC in pharmaceutical production technology from College Gerald Godin and possesses expertise in various solid oral forms processes.
Work at Corealis Pharma
Sarah Doughan has been employed at Corealis Pharma Inc. as an Opératrice en production pharmaceutique since 2014. In this role, she is involved in various aspects of pharmaceutical production, contributing to the manufacturing processes that ensure the quality and efficacy of pharmaceutical products. Her tenure at Corealis Pharma spans a decade, during which she has developed a comprehensive understanding of production operations.
Education and Expertise
Sarah Doughan studied at College Gerald Godin, where she focused on Technologie de la production pharmaceutique. She completed her studies in 2014, earning a DEC after three years of education. Her academic background has equipped her with the necessary skills to handle various solid oral forms processes, including wet granulation, dry granulation, direct compression, powder mixing, extrusion, spheronization, and coating.
Background
Sarah Doughan has over a decade of experience in the pharmaceutical industry, specifically within the Greater Montreal Metropolitan Area. Her career began after completing her education, and she has since gained extensive experience in the pharmaceutical production process. This includes responsibilities from sampling raw materials to the final stages of packaging and labeling.
Pharmaceutical Production Experience
Throughout her career, Sarah Doughan has developed expertise in various stages of pharmaceutical production. She is knowledgeable in processes such as sampling raw materials, which is critical for ensuring quality control, as well as packaging and labeling, which are essential for compliance and product distribution. Her experience encompasses a wide range of production techniques, making her a valuable asset in the pharmaceutical manufacturing sector.